Updated on 30 October 2013
Para-aortic blood pump (PABP) is a new type of left ventricular assist device that could enter humans trials in two years
Singapore: The Heart Science and Medical Devices Research Center, National Cheng Kung University, Taiwan (NCKU HSDMRC), and the division of cardiothoracic surgery, department of surgery, Duke University, US, have jointly carried out a cardiac assist device implantation on a calf.
Mr Roberto Manson and Mr Mani Daneshmand from Duke University Medical Center attended the workshop of Duke-NCKU collaboration on early interventional ventricular assist device hosted by NCKU and participated in the para-aortic blood pump (PABP) implantation surgery on calf.
Professor Pong-Jeu Lu, director, NCKU HSDMRC, had led his research team to develop the PABP for over thirteen years.
He said, "PABP is a new type of left ventricular assist device which has completed major design, prototype manufacturing and testing after more than 10 years of effort."
"This study could be extended to humans where clinical trials are to be conducted within the next two years, which will benefit more patients with heart failure in the future," Mr Manson said.